Assessing Risk Prediction Models Using Individual Participant Data From Multiple Studies
暂无分享,去创建一个
Mark Woodward | Shah Ebrahim | Johan Sundström | Georg Schett | Hans L. Hillege | Ying Zhang | Simon G. Thompson | Vilmundur Gudnason | Lewis H. Kuller | Hermann Brenner | Stephen Kaptoge | Paul M. Ridker | Altan Onat | Ralph B. D'Agostino | JoAnn E. Manson | Steven Shea | Giel Nijpels | Mary Cushman | Ron T. Gansevoort | Stephan J. L. Bakker | Brendan M. Buckley | Else-Marie Bladbjerg | Anne Tybjærg-Hansen | Philippe Amouyel | Jean Ferrières | Nicholas J. Wareham | Albert Hofman | Philip Haycock | John Danesh | Veikko Salomaa | Mika Kivimäki | Nancy Cook | David J. Couper | Yutaka Kiyohara | Ian R. White | Michael Marmot | Erkki Vartiainen | Jukka T. Salonen | Christie M. Ballantyne | Kay-Tee Khaw | Richard W. Morris | Stela McLachlan | Peter Willeit | Johann Willeit | Jackie F. Price | Jussi Kauhanen | Gunnar Sigurdsson | Eric Brunner | Adam S. Butterworth | Angela Döring | Bruce M. Psaty | Josef Coresh | Angela M. Wood | John Gallacher | Pei Gao | Thor Aspelund | Daichi Shimbo | Oscar H. Franco | Naveed Sattar | Debbie A. Lawlor | Robert Clarke | Jonathan A. Shaffer | J. Gallacher | J. Danesh | R. Collins | O. Franco | A. Hofman | J. Manson | E. Rimm | D. Lawlor | V. Salomaa | E. Vartiainen | T. Jørgensen | R. D'Agostino | N. Cook | M. Woodward | P. Ridker | V. Gudnason | H. Brenner | I. White | A. Wood | J. Buring | A. Folsom | D. Couper | J. Witteman | J. Coresh | L. Kuller | B. Psaty | E. Barrett-Connor | B. Howard | N. Sattar | S. Hankinson | M. Marmot | M. Stampfer | A. Evans | D. Arveiler | A. Döring | M. Kivimäki | R. Gillum | B. Schöttker | P. Jousilahti | J. Salonen | P. Amouyel | G. Nijpels | J. Dekker | N. Wareham | G. Sigurdsson | S. Kiechl | P. Willeit | J. Willeit | S. Ebrahim | M. Mussolino | R. Westendorp | H. Müller | D. Wingard | A. Fletcher | T. Aspelund | R. Clarke | T. Meade | S. Shea | C. Ballantyne | J. Price | K. Khaw | J. Ferrières | T. Ninomiya | E. Brunner | S. Kaptoge | E. Angelantonio | A. Butterworth | M. Kavousi | S. McLachlan | A. Onat | S. Thompson | Amanda J Lee | M. Cushman | B. Buckley | H. Hillege | J. Sundström | S. Bakker | I. Ford | R. Gansevoort | J. Jansson | R. Morris | P. Haycock | Y. Kiyohara | H. Arima | J. Yarnell | C. Stehouwer | S. Kirkland | M. Shipley | R. Tracy | J. Cooper | D. Shimbo | G. Schett | G. Grandits | J. Pai | J. Shepherd | S. Cobbe | J. Shaffer | Ying Zhang | L. Best | R. Bettencourt | A. Tybjærg‐Hansen | B. Lamarche | P. Wennberg | E. Bladbjerg | J. Kauhanen | M. Walker | M. Alexander | L. Pennells | P. Gao | D. Wormser | B. Thórsson | Rory Collins | Torben Jørgensen | Pekka Jousilahti | Ben Schöttker | Benoît Lamarche | Ian Ford | Kennet Harald | Aaron R. Folsom | Maryam Kavousi | Eric B. Rimm | Jan-Håkan Jansson | Michele Robertson | Elizabeth Barrett-Connor | Y. Doi | Jacqueline M. Dekker | Coen D. A. Stehouwer | Stefan Kiechl | James Shepherd | Alun Evans | Dominique Arveiler | Lisa Pennells | Robert W. Tipping | S. Goya Wannamethee | John W. Yarnell | Russ Tracy | Amanda J. Lee | Heiko Müller | Patrik Wennberg | Hisatomi Arima | Yasufumi Doi | Toshiharu Ninomiya | Tom W. Meade | Jackie A. Cooper | Greg Grandits | Richard F. Gillum | Michael Mussolino | Sue E. Hankinson | Jennifer K. Pai | Susan Kirkland | Rudi G. Westendorp | Bernard Cantin | Deborah L. Wingard | Richele Bettencourt | Bolli Thorsson | Jacqueline C. Witteman | Barbara V. Howard | Lyle Best | Jason G. Umans | J. Michael Gaziano | Meir Stampfer | Astrid Fletcher | Martin Shipley | Julie Buring | Stuart M. Cobbe | Matthew Walker | Sarah Watson | Myriam Alexander | Emanuele Di Angelantonio | David Wormser | J. Umans | M. Robertson | B. Cantin | K. Harald | S. Goya Wannamethee | R. Tipping | S. Watson | J. Michael Gaziano | A. Evans | J. Coresh | H. Müller | A. Hofman | B. Psaty | J. Cooper | J. Price | Heiko Müller
[1] F. Harrell,et al. Evaluating the yield of medical tests. , 1982, JAMA.
[2] D. Easton,et al. Cancer incidence in BRCA1 mutation carriers , 2003 .
[3] V. Beral,et al. Breast cancer and abortion: collaborative reanalysis of data from 53 epidemiological studies, including 83 000 women with breast cancer from 16 countries , 2004, The Lancet.
[4] E L Korn,et al. Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. , 1997, American journal of epidemiology.
[5] J. Benichou,et al. Choice of time‐scale in Cox's model analysis of epidemiologic cohort data: a simulation study , 2004, Statistics in medicine.
[6] S. Thompson,et al. How should meta‐regression analyses be undertaken and interpreted? , 2002, Statistics in medicine.
[7] Richard D Riley,et al. Rejoinder to commentaries on ‘Multivariate meta‐analysis: Potential and promise’ , 2011 .
[8] David R. Cox,et al. Regression models and life tables (with discussion , 1972 .
[9] Dan Jackson,et al. Multivariate meta-analysis: Potential and promise , 2011, Statistics in medicine.
[10] A. Evans,et al. Residual coronary risk in men aged 50–59 years treated for hypertension and hyperlipidaemia in the population: the PRIME study , 2004, Journal of hypertension.
[11] P. Macfarlane,et al. The design of a prospective study of Pravastatin in the Elderly at Risk (PROSPER). PROSPER Study Group. PROspective Study of Pravastatin in the Elderly at Risk. , 1999, The American journal of cardiology.
[12] M. Gonen,et al. Concordance probability and discriminatory power in proportional hazards regression , 2005 .
[13] Holly Janes,et al. Matching in Studies of Classification Accuracy: Implications for Analysis, Efficiency, and Assessment of Incremental Value , 2008, Biometrics.
[14] Patrick Royston,et al. Explained Variation for Survival Models , 2006 .
[15] E. Riboli,et al. Diet and cancer — the European Prospective Investigation into Cancer and Nutrition , 2004, Nature Reviews Cancer.
[16] S R Lipsitz,et al. A Global Goodness‐of‐Fit Statistic for Cox Regression Models , 1999, Biometrics.
[17] Stephen Kaptoge,et al. Statistical methods for the time-to-event analysis of individual participant data from multiple epidemiological studies , 2010, International journal of epidemiology.
[18] M. Woodward,et al. Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. , 2012, JAMA.
[19] Patrik Magnusson,et al. American Journal of Epidemiology Practice of Epidemiology Risk Prediction Measures for Case-cohort and Nested Case-control Designs: an Application to Cardiovascular Disease , 2022 .
[20] Daniel B. Mark,et al. TUTORIAL IN BIOSTATISTICS MULTIVARIABLE PROGNOSTIC MODELS: ISSUES IN DEVELOPING MODELS, EVALUATING ASSUMPTIONS AND ADEQUACY, AND MEASURING AND REDUCING ERRORS , 1996 .
[21] Vittorio Krogh,et al. Methods for pooling results of epidemiologic studies: the Pooling Project of Prospective Studies of Diet and Cancer. , 2006, American journal of epidemiology.
[22] C.J.H. Mann,et al. Clinical Prediction Models: A Practical Approach to Development, Validation and Updating , 2009 .
[23] M. Kenward,et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls , 2009, BMJ : British Medical Journal.
[24] A. Rodgers,et al. Determinants of cardiovascualar disease in the Asia Pacific region: protocol for a collaborative overview of cohort studies , 1999 .
[25] R. Newson. Confidence Intervals for Rank Statistics: Somers’ D and Extensions , 2006 .
[26] R. Collins,et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths , 2007, The Lancet.
[27] M. Pencina,et al. On the C‐statistics for evaluating overall adequacy of risk prediction procedures with censored survival data , 2011, Statistics in medicine.
[28] Alicja R. Rudnicka,et al. Measures to assess the prognostic ability of the stratified Cox proportional hazards model , 2009, Statistics in medicine.
[29] E. Steyerberg. Clinical Prediction Models , 2008, Statistics for Biology and Health.
[30] J. Danesh,et al. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies , 2011, The Lancet.
[31] David W. Hosmer,et al. Applied Logistic Regression , 1991 .
[32] F. Harrell,et al. Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors , 2005 .
[33] Michael J Pencina,et al. Choice of time scale and its effect on significance of predictors in longitudinal studies , 2007, Statistics in medicine.
[34] S. Kiechl,et al. Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Bruneck study. , 2003, Diabetes care.
[35] Richard D Riley,et al. Interpretation of random effects meta-analyses , 2011, BMJ : British Medical Journal.
[36] P. Elliott,et al. The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine. , 2008, International journal of epidemiology.
[37] A. Uitterlinden,et al. The Association between Common Vitamin D Receptor Gene Variations and Osteoporosis: A Participant-Level Meta-Analysis , 2006, Annals of Internal Medicine.
[38] Ewout W Steyerberg,et al. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers , 2011, Statistics in medicine.
[39] J. Gallacher,et al. Lipid-related markers and cardiovascular disease prediction. , 2012, JAMA.
[40] Gioacchino Leandro,et al. Meta-Analysis in Medical Research: The Handbook for the Understanding and Practice of Meta-Analysis , 2005 .
[41] S. Thompson,et al. Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.
[42] M. Pencina,et al. Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond , 2008, Statistics in medicine.
[43] Ian R. White,et al. Multivariate Random-effects Meta-analysis , 2009 .
[44] J. Gallacher,et al. C-reactive protein, fibrinogen, and cardiovascular disease prediction. , 2012, The New England journal of medicine.
[45] Patrick Royston,et al. Construction and validation of a prognostic model across several studies, with an application in superficial bladder cancer , 2004, Statistics in medicine.
[46] Patrick Royston,et al. A new measure of prognostic separation in survival data , 2004, Statistics in medicine.
[47] D.,et al. Regression Models and Life-Tables , 2022 .
[48] S J Pocock,et al. Prognostic scores for detecting a high risk group: estimating the sensitivity when applied to new data. , 1990, Statistics in medicine.
[49] H Tunstall-Pedoe,et al. The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases , 2007, European Journal of Epidemiology.
[50] K. Covinsky,et al. Assessing the Generalizability of Prognostic Information , 1999, Annals of Internal Medicine.